News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
Ripple ($XRP) Turns Bullish with $1.57 Breakout Target in Sight
BlockchainReporter·2026/05/11 10:21
Revolut Technical Glitch Showed Bitcoin at $0.02, Triggering Mass Double-takes
Cryptonewsland·2026/05/11 10:21
Top 3 Price Prediction: BTC holds gains, ETH closes above key resistance, XRP eyes bullish channel breakout
CryptoNewsNet·2026/05/11 10:12
Why a Top AI Gainer is Now the Market’s Worst Performer
CryptoNewsNet·2026/05/11 10:12
Uniswap climbs as TVL hits $3.59B – Can UNI hold above $3.90?
CryptoNewsNet·2026/05/11 10:12
BlackRock Expands Tokenized Finance Push With New Treasury Fund Filings
post-161736
post-161736
post-161736
Newscrypto·2026/05/11 10:09
XRP price forms inverse H&S pattern, can bulls push it above $1.50?
Crypto.News·2026/05/11 10:09
Top XRP Validator Becomes Director At XRPL Foundation
TimesTabloid·2026/05/11 10:03
Fortune Protocol Completes Seed Round Financing, Accelerating AI-Powered Prediction Market Innovation
The Block·2026/05/11 10:03
Flash
16:58
In the past 24 hours, the MarketVectorTM Digital Assets 100 Small Cap Index dropped 0.87%, currently standing at 2285.71 points. During a V-shaped rebound, the index hit its period low of 2260.26 at 07:37 (GMT+8), and in a round of spike and retracement, reached a period high of 2331.37 at 21:50.MarketVectorTM Digital Assets 100 Mid-Cap Index rose by 0.43% to 2,662.57 points. During the period, it reached a low of 2,598.96 points at 07:36 (UTC+8) and a high of 2,699.43 points at 21:50 (UTC+8). The MarketVector Digital Assets 100 Index increased by 0.71% to 12,806.37 points. Currently, Solana is down by 1.93%, Dogecoin is down by 0.28%, and XRP is down by 0.67%. Bitcoin is up by 0.86%, currently at $64,687.74; Ethereum is up by 0.31%, currently at $1,738.19.
16:54
LME copper futures closed up by $54, at $13,649 per ton.LME aluminum futures closed down by 32 USD, at 3,364 USD/ton. LME zinc futures closed up by 52 USD, at 3,608 USD/ton.
16:52
Arrowhead Pharmaceuticals announced that its drug Redemplo® (Plozasiran) has received marketing authorization from the European Commission for lowering triglyceride levels in adult patients with familial chylomicronemia syndrome (FCS).FCS is a rare and severe genetic disease characterized by extremely high levels of triglycerides in the blood, which can lead to life-threatening pancreatitis. This approval marks a significant advancement for Arrowhead Pharmaceuticals in the field of rare disease treatments, providing a new treatment option for FCS patients in Europe. The company stated that it is committed to bringing this innovative therapy to patients in need as soon as possible.
Trending news
MoreIn the past 24 hours, the MarketVectorTM Digital Assets 100 Small Cap Index dropped 0.87%, currently standing at 2285.71 points. During a V-shaped rebound, the index hit its period low of 2260.26 at 07:37 (GMT+8), and in a round of spike and retracement, reached a period high of 2331.37 at 21:50.
Japan’s Pension Bet & Digital Push Put XRP Back In The Limelight